Geng Yue, Narasipura Srinivas, Seigel Gail M, King Michael R
Department of Biomedical Engineering, Cornell University, 205 Weill Hall, 14853 Ithaca, NY, USA.
Center for Hearing and Deafness, University at Buffalo, Buffalo, NY, USA.
Cell Mol Bioeng. 2010 Dec 1;3(4):361-368. doi: 10.1007/s12195-010-0145-8.
Retinoblastoma (RB) is a retinal cancer of childhood. RB survivors tend to develop additional tumors later in life, although the physical mechanisms of RB metastatic spread are largely unknown. One step in metastasis through the blood stream is tumor cell adherence to the blood vessel wall through specific receptor:ligand interactions. Yet, human RB cell lines RB143 and WERI-Rb27 do express selectin ligands or beta-2 integrins and cannot directly interact with inflamed endothelium. In this study, we show that RB cells express ICAM-1, a beta-2 integrin ligand that correlates with metastasis and is preferentially co-expressed on RB cells that also express ABCG2, a stem cell marker associated with chemoresistance and metastasis. Based on the presence of ICAM-1+ RB cells, we tested the hypothesis that RB cells could be recruited to an E-selectin surface via attachment to activated polymorphonuclear cells (PMNs). We characterized the dynamic adhesion between RB cells and PMNs within E-selectin coated microtubes under a physiological range of wall shear stress values (0.2-5 dyn/cm). We show that activated PMNs are necessary for the recruitment of RB cells through ICAM-1:LFA-1 binding. Results from this work may lead to new strategies that target the metastatic spread of tumor cells.
视网膜母细胞瘤(RB)是一种儿童期视网膜癌症。RB幸存者在日后生活中往往会发生其他肿瘤,尽管RB转移扩散的生理机制很大程度上尚不清楚。肿瘤细胞通过特定受体与配体的相互作用附着于血管壁是肿瘤通过血流发生转移的其中一个步骤。然而,人RB细胞系RB143和WERI-Rb27并不表达选择素配体或β-2整合素,无法直接与炎症内皮细胞相互作用。在本研究中,我们发现RB细胞表达细胞间黏附分子-1(ICAM-1),这是一种与转移相关的β-2整合素配体,且优先共表达于也表达ABCG2的RB细胞上,ABCG2是一种与化疗耐药性和转移相关的干细胞标志物。基于ICAM-1+RB细胞的存在,我们检验了RB细胞可通过附着于活化的多形核细胞(PMN)而被募集至E-选择素表面的假说。我们在生理范围的壁面剪应力值(0.2-5达因/平方厘米)下,对E-选择素包被的微管内RB细胞与PMN之间的动态黏附进行了表征。我们发现活化的PMN对于通过ICAM-1:LFA-1结合募集RB细胞是必需的。这项工作的结果可能会带来针对肿瘤细胞转移扩散的新策略。